These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 7944063)
1. Restriction isotyping of apoprotein E. Sack MN; Hoeg JM Ann Intern Med; 1994 Nov; 121(10):816. PubMed ID: 7944063 [No Abstract] [Full Text] [Related]
2. Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia. Hsia SH; Connelly PW; Hegele RA J Investig Med; 1995 Apr; 43(2):187-94. PubMed ID: 7735921 [TBL] [Abstract][Full Text] [Related]
3. [Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes]. Borghini I; James RW; Pometta D Schweiz Med Wochenschr; 1989 Dec; 119(50):1821-4. PubMed ID: 2609136 [TBL] [Abstract][Full Text] [Related]
4. Xanthoma striatum palmare as an early sign of familial type III hyperlipoproteinemia with an apoprotein E genotype epsilon2/epsilon2. Sato-Matsumura KC; Matsumura T; Yokoshiki H; Chiba H; Shimizu H Clin Exp Dermatol; 2003 May; 28(3):321-2. PubMed ID: 12780724 [No Abstract] [Full Text] [Related]
5. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. Falko JM; Schonfeld G; Witztum JL; Kolar JB; Weidman SW; Steelman R J Clin Endocrinol Metab; 1980 Mar; 50(3):521-8. PubMed ID: 7358833 [No Abstract] [Full Text] [Related]
6. Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping. Walden CC; Huff MW; Leiter LA; Connelly PW; Hegele RA J Clin Endocrinol Metab; 1994 Mar; 78(3):699-704. PubMed ID: 7907341 [TBL] [Abstract][Full Text] [Related]
8. [Genetic variants of apo E: significance for triglyceride metabolism]. Mann WA; Brewer HB; Greten H Z Gastroenterol Verh; 1991 Mar; 26():106. PubMed ID: 1714116 [No Abstract] [Full Text] [Related]
9. Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Ghiselli G; Schaefer EJ; Gascon P; Breser HB Science; 1981 Dec; 214(4526):1239-41. PubMed ID: 6795720 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E in hyperlipidemia. Walden CC; Hegele RA Ann Intern Med; 1994 Jun; 120(12):1026-36. PubMed ID: 8185134 [TBL] [Abstract][Full Text] [Related]
11. Effect of infusion of normal plasma on lipoproteins in type III hyperlipoproteinemia. Stuyt PM; Demacker PN; van 't Laar A Horm Metab Res; 1981 Dec; 13(12):715-6. PubMed ID: 7319472 [No Abstract] [Full Text] [Related]
12. Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian. Tate JR; Hoffmann MM; Lovelock PK; Kesting JB; Shaw JT Ann Clin Biochem; 2001 Jan; 38(Pt 1):46-53. PubMed ID: 11270841 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4. van den Maagdenberg AM; de Knijff P; Stalenhoef AF; Gevers Leuven JA; Havekes LM; Frants RR Biochem Biophys Res Commun; 1989 Dec; 165(2):851-7. PubMed ID: 2597162 [TBL] [Abstract][Full Text] [Related]
15. [Hyperlipoproteinemia type III with apolipoprotein E phenotype 2/2]. Engst R Hautarzt; 1985 Nov; 36(11):629-34. PubMed ID: 4077508 [TBL] [Abstract][Full Text] [Related]
16. Characterization of apolipoprotein E (ApoE) apoprotein levels in the various ApoE phenotypes. Suarez BK; Schonfeld G J Clin Endocrinol Metab; 1981 Aug; 53(2):435-8. PubMed ID: 7251821 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotyping in Alzheimer's disease. Humphries S; Betteridge DJ; Durrington PN; Galton DJ; Nicholls P Lancet; 1996 Jun; 347(9017):1776. PubMed ID: 8656945 [No Abstract] [Full Text] [Related]